Chandra Bhagat Pharma Limited Profit Margin

The latest profit margin for CBPL.BO is 1.9% as of March 2026. That compares with 0.71% in the prior-year period — up 167.6% year over year. That is below the sector sector average of 13.2%. Investors often review this figure alongside Chandra Bhagat Pharma Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, CBPL.BO's profit margin moved from 0.71% to 1.9% — a 167.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Chandra Bhagat Pharma Limited's valuation or profitability profile.

Against its sector companies, CBPL.BO currently prints 1.9% for profit margin, while the sector average sits near 13.2%. That is roughly 85.6% below the sector mean. Large gaps often invite a closer look at Chandra Bhagat Pharma Limited's growth, margins, and balance sheet.

Profit Margin shows how effectively Chandra Bhagat Pharma Limited converts resources into returns. At 1.9%, CBPL.BO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 0.71% in the prior-year period — up 167.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CBPL.BO's profit margin (1.9%), review year-over-year change from 0.71%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.